rss
Arch Dis Child Fetal Neonatal Ed 2007;92:F320-F324 doi:10.1136/adc.2006.106039
  • Review

Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?

  1. Afif El-Khuffash,
  2. Eleanor J Molloy
  1. Department of Neonatology, National Maternity Hospital, Dublin, Ireland
  1. Correspondence to:
    Eleanor J Molloy
    Department of Neonatology, National Maternity Hospital, Holles St, Dublin 2, Ireland; elesean{at}hotmail.com
  • Accepted 27 November 2006

Abstract

B-type natriuretic peptide (BNP) and N-terminal-pro-BNP (NTpBNP) have a major role in screening and diagnosis of cardiac disease and monitoring of the treatment response in children and adults. This review discusses the evidence underpinning the potential benefits of these natriuretic peptides in neonatology. They may serve as a useful adjunct to echocardiography in the diagnosis of patent ductus arteriosus and its response to treatment and the diagnosis of persistent pulmonary hypertension of the newborn. However, more work is needed to explore the possible roles of BNP/NTpBNP in the management of sepsis and monitoring of cardiac performance in neonates.

Footnotes

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.